首页> 中文期刊> 《中国医药导报》 >子宫动脉介入治疗对宫颈癌患者血清肿瘤标志物及瘤体内血流的影响观察

子宫动脉介入治疗对宫颈癌患者血清肿瘤标志物及瘤体内血流的影响观察

         

摘要

目的 研究分析子宫动脉介入治疗对宫颈癌患者血清肿瘤标志物及瘤体内血流的影响.方法选取2008年3月~2011年8月于本院进行治疗的70例宫颈癌患者为研究对象,将所有患者治疗前及治疗后3、7、10、14 d的血清肿瘤标志物及瘤体内血流指标进行检测及比较.结果 70例宫颈癌患者治疗前及治疗后3、7、10、14 d的血清肿瘤标志物水平均呈现持续降低的趋势,且阻力指数(RI)持续增大,血管指数(VI)、血流指数(FI)、血管血流指数(VFI)、搏动指数(PI)及血流最大速度(Vmax)均持续减小,治疗后不同时间段上述指标与治疗前比较,差异均有统计学意义(均P < 0.05).结论子宫动脉介入治疗对宫颈癌患者血清肿瘤标志物及瘤体内血流的影响较为明显,肯定了其在本病治疗中的临床效果.%Objective To study and analyze the influence of uterine artery interventional therapy for the serum tumor markers and tumor body blood flow of patients with cervical cancer. Methods 70 patients with cervical cancer in our hospital from March 2008 to August 2011 were selected as research object, and the serum tumor markers and tumor body blood flow of all the patients before and after the treatment at third, seventh, tenth and fourteenth day were detected and compared. Results The serum tumor markers of 70 patients with cervical cancer before and after the treatment at third, seventh, tenth and fourteenth day continuously decreased, and resistance index (RI) continuously increased,vascularity index (VI), blood flow index (FI), Vascular-blood flow index (VFI), pulsatility index (PI) and maximum velocity of blood flow (Vmax) continuously decreased, the levels after the treatment at different times were compared to those before the treatment, there were all significant differences (all P < 0.05). Conclusion The influence of uterine artery interventional therapy for the serum tumor markers and tumor body blood flow of patients with cervical cancer is obvious, and it affirms the effect of the treatment for cervical cancer.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号